153 related articles for article (PubMed ID: 33739868)
1. Use of Vascular Endothelial Growth Factor-D As a Targeted Therapy in Lymphedema Treatment: A Comprehensive Literature Review.
Forte AJ; Boczar D; Huayllani MT; Anastasiadis PZ; McLaughlin SA
Lymphat Res Biol; 2022 Feb; 20(1):3-6. PubMed ID: 33739868
[No Abstract] [Full Text] [Related]
2. Utilization of Vascular Endothelial Growth Factor-C156S in Therapeutic Lymphangiogenesis: A Systematic Review.
Forte AJ; Boczar D; Huayllani MT; Anastasiadis PZ; McLaughlin S
Lymphat Res Biol; 2022 Dec; 20(6):580-584. PubMed ID: 35501971
[No Abstract] [Full Text] [Related]
3. Growth factor therapy and lymph node graft for lymphedema.
Tervala TV; Hartiala P; Tammela T; Visuri MT; Ylä-Herttuala S; Alitalo K; Saarikko AM
J Surg Res; 2015 Jun; 196(1):200-7. PubMed ID: 25777822
[TBL] [Abstract][Full Text] [Related]
4. VEGF-C and VEGF-C156S in the pro-lymphangiogenic growth factor therapy of lymphedema: a large animal study.
Visuri MT; Honkonen KM; Hartiala P; Tervala TV; Halonen PJ; Junkkari H; Knuutinen N; Ylä-Herttuala S; Alitalo KK; Saarikko AM
Angiogenesis; 2015 Jul; 18(3):313-26. PubMed ID: 26018927
[TBL] [Abstract][Full Text] [Related]
5. Differential Receptor Binding and Regulatory Mechanisms for the Lymphangiogenic Growth Factors Vascular Endothelial Growth Factor (VEGF)-C and -D.
Davydova N; Harris NC; Roufail S; Paquet-Fifield S; Ishaq M; Streltsov VA; Williams SP; Karnezis T; Stacker SA; Achen MG
J Biol Chem; 2016 Dec; 291(53):27265-27278. PubMed ID: 27852824
[TBL] [Abstract][Full Text] [Related]
6. Distinct roles of vascular endothelial growth factor-D in lymphangiogenesis and metastasis.
Kopfstein L; Veikkola T; Djonov VG; Baeriswyl V; Schomber T; Strittmatter K; Stacker SA; Achen MG; Alitalo K; Christofori G
Am J Pathol; 2007 Apr; 170(4):1348-61. PubMed ID: 17392173
[TBL] [Abstract][Full Text] [Related]
7. Endothelin-1 cooperates with hypoxia to induce vascular-like structures through vascular endothelial growth factor-C, -D and -A in lymphatic endothelial cells.
Garrafa E; Caprara V; Di Castro V; Rosanò L; Bagnato A; Spinella F
Life Sci; 2012 Oct; 91(13-14):638-43. PubMed ID: 22552325
[TBL] [Abstract][Full Text] [Related]
8. Experimental assessment of pro-lymphangiogenic growth factors in the treatment of post-surgical lymphedema following lymphadenectomy.
Baker A; Kim H; Semple JL; Dumont D; Shoichet M; Tobbia D; Johnston M
Breast Cancer Res; 2010; 12(5):R70. PubMed ID: 20825671
[TBL] [Abstract][Full Text] [Related]
9. Growth factor therapy and autologous lymph node transfer in lymphedema.
Lähteenvuo M; Honkonen K; Tervala T; Tammela T; Suominen E; Lähteenvuo J; Kholová I; Alitalo K; Ylä-Herttuala S; Saaristo A
Circulation; 2011 Feb; 123(6):613-20. PubMed ID: 21282502
[TBL] [Abstract][Full Text] [Related]
10. Peritumoral lymphangiogenesis induced by vascular endothelial growth factor C and D promotes lymph node metastasis in breast cancer patients.
Zhao YC; Ni XJ; Li Y; Dai M; Yuan ZX; Zhu YY; Luo CY
World J Surg Oncol; 2012 Aug; 10():165. PubMed ID: 22906075
[TBL] [Abstract][Full Text] [Related]
11. Expression of VEGF-C and VEGF-D as significant markers for assessment of lymphangiogenesis and lymph node metastasis in non-small cell lung cancer.
Feng Y; Wang W; Hu J; Ma J; Zhang Y; Zhang J
Anat Rec (Hoboken); 2010 May; 293(5):802-12. PubMed ID: 20225197
[TBL] [Abstract][Full Text] [Related]
12. Lymphangiogenesis and angiogenesis in bladder cancer: prognostic implications and regulation by vascular endothelial growth factors-A, -C, and -D.
Miyata Y; Kanda S; Ohba K; Nomata K; Hayashida Y; Eguchi J; Hayashi T; Kanetake H
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):800-6. PubMed ID: 16467091
[TBL] [Abstract][Full Text] [Related]
13. Synaptonemal complex protein 3 is associated with lymphangiogenesis in non-small cell lung cancer patients with lymph node metastasis.
Kitano H; Chung JY; Noh KH; Lee YH; Kim TW; Lee SH; Eo SH; Cho HJ; Choi CH; Inoue S; Hanaoka J; Fukuoka J; Hewitt SM
J Transl Med; 2017 Jun; 15(1):138. PubMed ID: 28623914
[TBL] [Abstract][Full Text] [Related]
14. Extracorporeal shock wave therapy combined with vascular endothelial growth factor-C hydrogel for lymphangiogenesis.
Kim IG; Lee JY; Lee DS; Kwon JY; Hwang JH
J Vasc Res; 2013; 50(2):124-33. PubMed ID: 23208012
[TBL] [Abstract][Full Text] [Related]
15. Lymph node transfer and perinodal lymphatic growth factor treatment for lymphedema.
Honkonen KM; Visuri MT; Tervala TV; Halonen PJ; Koivisto M; Lähteenvuo MT; Alitalo KK; Ylä-Herttuala S; Saaristo AM
Ann Surg; 2013 May; 257(5):961-7. PubMed ID: 23013803
[TBL] [Abstract][Full Text] [Related]
16. Serum level of VEGF-D in patients with primary lymphedema.
Fink AM; Kaltenegger I; Schneider B; Frühauf J; Jurecka W; Steiner A
Lymphology; 2004 Dec; 37(4):185-9. PubMed ID: 15693535
[TBL] [Abstract][Full Text] [Related]
17. Molecular control of lymphatic metastasis.
Achen MG; Stacker SA
Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
[TBL] [Abstract][Full Text] [Related]
18. Lymphangiogenesis and Lymphangiogenic Growth Factors.
Hartiala P; Saarikko AM
J Reconstr Microsurg; 2016 Jan; 32(1):10-5. PubMed ID: 25665098
[TBL] [Abstract][Full Text] [Related]
19. Differential mRNA and tissue expression of lymphangiogenic growth factors (VEGF-C and -D) and their receptor (VEGFR-3) during tail regeneration in a gecko.
Blacker HA; Orgeig S
J Comp Physiol B; 2012 Jan; 182(1):109-26. PubMed ID: 21800152
[TBL] [Abstract][Full Text] [Related]
20. A High-Fat Diet in the Absence of Obesity Increases Lymphangiogenesis by Inducing VEGF-C in a Murine Lymphedema Model.
Choi J; Kim J; Kim J; Jeong W; Jo T; Lee HW; Park YS; Park SW
Plast Reconstr Surg; 2023 Jul; 152(1):87-96. PubMed ID: 36730763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
